MBL International Acquires Antibody Business From LifeSpan BioSciences, Inc.
Published: Feb 14, 2006
Tokyo, Feb 14, 2006 (JCN) - Medical and Biological Laboratories (MBL) announced on February 13 that its Massachusetts-based subsidiary MBL International has acquired the antibody business of LifeSpan BioSciences (LifeSpan) of Seattle.
LifeSpan is a bio venture company that offers a wide range of antibodies, namely more than 900 types including 800 GPCR (G-protein coupled receptor) antibodies.
With this move, MBL International now has more than 4,000 antibody products. Accordingly, it will promote its sales initiatives in the global market.